Peptide record

TPDB10040

Piscidin 3 Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity standard
22 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB10040
Piscidin 3
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Hemolysis Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia ACP740 _ACP240 AntiCP 2.0 CancerPPD 2.0 iACP-DRLF AFP-GFuse Antifungipept CAFPdb i2APP AI4AVP dbAMP 3.0 DRAVP 2.0 APD_complete APD_hemolytic HemoPI Hemolytic2 PD_Hemolysis ToxinPred 3.0
standard
No
A 22-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
FIHHIFRGIVHAGRSIGRFLTG
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C116H179N37O25
NDCEQKMPWY
GI
2491.93
12.70
6
0
10
+3
0.98
0.455
106.36
Mammalian: 1.1 hour Yeast: 3 min E.coli: 2 min
0
0.00
2
Residue Composition
number
1
A
3
R
0
N
0
D
0
C
0
E
0
Q
4
G
3
H
4
I
1
L
0
K
0
M
3
F
0
P
1
S
1
T
0
W
0
Y
1
V
Amino Acid Distribution
A: 1 R: 3 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 4 H: 3 I: 4 L: 1 K: 0 M: 0 F: 3 P: 0 S: 1 T: 1 W: 0 Y: 0 V: 1
Chemical Descriptors
22 reviewed residue count
C116H179N37O25 sequence-only estimate (linear, free termini)
2491.93 sequence-only estimate (linear, free termini)
12.70 sequence-only estimate (linear, free termini)
+3 sequence-only estimate (linear, free termini)
0.98 sequence-only estimate (linear, free termini)
0.455 sequence-only estimate (linear, free termini)
Free Activity
L Activity
Linear Activity
Free Activity
Anticancer Activity
Morone chrysops x Morone saxatilis Activity
Evidence Records 34 records
Evidence 1 Activity

Activity

MIC
Antibacterial
2.51 µM

Target

S. iniae

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
fish pathogens S. iniae (MIC 2.51 uM), L. garvieae (MIC 20.07 uM), V. anguillarum (MIC 2.51-5.02 uM), A-salmonicida (MIC >80.26
Evidence 2 Activity

Activity

MIC
Antibacterial
20.07 µM

Target

L. garvieae

Source & Reference

dbAMP DRAMP

Other

fish pathogens S. iniae (MIC 2.51 uM), L. garvieae (MIC 20.07 uM), V. anguillarum (MIC 2.51-5.02 uM), A-salmonicida (MIC >80.26 uM), human pathogens E. fae
Evidence 3 Activity

Activity

MIC
Antibacterial
2.51-5.02 µM

Target

V. anguillarum

Source & Reference

dbAMP DRAMP

Other

fish pathogens S. iniae (MIC 2.51 uM), L. garvieae (MIC 20.07 uM), V. anguillarum (MIC 2.51-5.02 uM), A-salmonicida (MIC >80.26 uM), human pathogens E. faecalis (MIC 1.26 uM), S. flexneri (M
Evidence 4 Activity

Activity

MIC
Antibacterial
1.26 µM

Target

Enterococcus faecalis

Source & Reference

dbAMP DRAMP

Other

07 uM), V. anguillarum (MIC 2.51-5.02 uM), A-salmonicida (MIC >80.26 uM), human pathogens E. faecalis (MIC 1.26 uM), S. flexneri (MIC 20.07 uM), and E. coli (MIC 80.26 uM). Viruses: It is active against ch
Evidence 5 Activity

Activity

MIC
Antibacterial
20.07 µM

Target

S. flexneri

Source & Reference

dbAMP DRAMP

Other

2.51-5.02 uM), A-salmonicida (MIC >80.26 uM), human pathogens E. faecalis (MIC 1.26 uM), S. flexneri (MIC 20.07 uM), and E. coli (MIC 80.26 uM). Viruses: It is active against channel catfish virus (CCV), f
Evidence 6 Activity

Activity

MIC
Antibacterial
80.26 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

IC >80.26 uM), human pathogens E. faecalis (MIC 1.26 uM), S. flexneri (MIC 20.07 uM), and E. coli (MIC 80.26 uM). Viruses: It is active against channel catfish virus (CCV), frog virus 3 (FV3) (Chinchar
Evidence 7 Activity

Activity

IC50
IC50 = 26.01 µM
Anticancer
26.01 µM

Target

Fibrosarcoma
HT-1080
Not Available

Assay & Model

MTT assay
24-h

Source & Reference

dbAMP 3.0 CancerPPD 2.0
CancerPPD2
2021

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation. dbAMP 3.0 classified as Anticancer under the disease-associated peptide function classes.
Evidence 8 Activity

Activity

IC50
IC50 = 17.5 µM
Anticancer
17.5 µM

Target

Breast Cancer
MDA-MB-231
Breast

Assay & Model

MTT assay
24-h

Source & Reference

dbAMP 3.0 CancerPPD 2.0
CancerPPD2
2021
Evidence 9 Activity

Activity

IC50
IC50 = 21.6 µM
Anticancer
21.6 µM

Target

Lung Cancer
A-549
Lung

Assay & Model

MTT assay
24-h

Source & Reference

dbAMP 3.0 CancerPPD 2.0
CancerPPD2
2021
Evidence 10 Activity

Activity

IC50
IC50 = 18.1 µM
Anticancer
18.1 µM

Target

Cervical Cancer
HeLa
Cervix

Assay & Model

MTT assay
24-h

Source & Reference

dbAMP 3.0 CancerPPD 2.0
CancerPPD2
2021
Evidence 11 Activity

Activity

MIC
Antifungal
2.51 µM

Target

S. iniae

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
fish pathogens S. iniae (MIC 2.51 uM), L. garvieae (MIC 20.07 uM), V. anguillarum (MIC 2.51-5.02 uM), A-salmonicida (MIC >80.26
Evidence 12 Activity

Activity

MIC
Antifungal
20.07 µM

Target

L. garvieae

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

fish pathogens S. iniae (MIC 2.51 uM), L. garvieae (MIC 20.07 uM), V. anguillarum (MIC 2.51-5.02 uM), A-salmonicida (MIC >80.26 uM), human pathogens E. fae
Evidence 13 Activity

Activity

MIC
Antifungal
2.51-5.02 µM

Target

V. anguillarum

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

fish pathogens S. iniae (MIC 2.51 uM), L. garvieae (MIC 20.07 uM), V. anguillarum (MIC 2.51-5.02 uM), A-salmonicida (MIC >80.26 uM), human pathogens E. faecalis (MIC 1.26 uM), S. flexneri (M
Evidence 14 Activity

Activity

MIC
Antifungal
1.26 µM

Target

Enterococcus faecalis

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

07 uM), V. anguillarum (MIC 2.51-5.02 uM), A-salmonicida (MIC >80.26 uM), human pathogens E. faecalis (MIC 1.26 uM), S. flexneri (MIC 20.07 uM), and E. coli (MIC 80.26 uM). Viruses: It is active against ch
Evidence 15 Activity

Activity

MIC
Antifungal
20.07 µM

Target

S. flexneri

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

2.51-5.02 uM), A-salmonicida (MIC >80.26 uM), human pathogens E. faecalis (MIC 1.26 uM), S. flexneri (MIC 20.07 uM), and E. coli (MIC 80.26 uM). Viruses: It is active against channel catfish virus (CCV), f
Evidence 16 Activity

Activity

MIC
Antifungal
80.26 µM

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

IC >80.26 uM), human pathogens E. faecalis (MIC 1.26 uM), S. flexneri (MIC 20.07 uM), and E. coli (MIC 80.26 uM). Viruses: It is active against channel catfish virus (CCV), frog virus 3 (FV3) (Chinchar
Evidence 17 Activity

Activity

MIC
Antiparasitic
2.51 µM

Target

S. iniae

Source & Reference

dbAMP 3.0 DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets. dbAMP 3.0 classified under the Anti-parasitic function class.
fish pathogens S. iniae (MIC 2.51 uM), L. garvieae (MIC 20.07 uM), V. anguillarum (MIC 2.51-5.02 uM), A-salmonicida (MIC >80.26
Evidence 18 Activity

Activity

MIC
Antiparasitic
20.07 µM

Target

L. garvieae

Source & Reference

dbAMP 3.0 DRAMP

Other

fish pathogens S. iniae (MIC 2.51 uM), L. garvieae (MIC 20.07 uM), V. anguillarum (MIC 2.51-5.02 uM), A-salmonicida (MIC >80.26 uM), human pathogens E. fae
Evidence 19 Activity

Activity

MIC
Antiparasitic
2.51-5.02 µM

Target

V. anguillarum

Source & Reference

dbAMP 3.0 DRAMP

Other

fish pathogens S. iniae (MIC 2.51 uM), L. garvieae (MIC 20.07 uM), V. anguillarum (MIC 2.51-5.02 uM), A-salmonicida (MIC >80.26 uM), human pathogens E. faecalis (MIC 1.26 uM), S. flexneri (M
Evidence 20 Activity

Activity

MIC
Antiparasitic
1.26 µM

Target

Enterococcus faecalis

Source & Reference

dbAMP 3.0 DRAMP

Other

07 uM), V. anguillarum (MIC 2.51-5.02 uM), A-salmonicida (MIC >80.26 uM), human pathogens E. faecalis (MIC 1.26 uM), S. flexneri (MIC 20.07 uM), and E. coli (MIC 80.26 uM). Viruses: It is active against ch
Evidence 21 Activity

Activity

MIC
Antiparasitic
20.07 µM

Target

S. flexneri

Source & Reference

dbAMP 3.0 DRAMP

Other

2.51-5.02 uM), A-salmonicida (MIC >80.26 uM), human pathogens E. faecalis (MIC 1.26 uM), S. flexneri (MIC 20.07 uM), and E. coli (MIC 80.26 uM). Viruses: It is active against channel catfish virus (CCV), f
Evidence 22 Activity

Activity

MIC
Antiparasitic
80.26 µM

Target

Escherichia coli

Source & Reference

dbAMP 3.0 DRAMP

Other

IC >80.26 uM), human pathogens E. faecalis (MIC 1.26 uM), S. flexneri (MIC 20.07 uM), and E. coli (MIC 80.26 uM). Viruses: It is active against channel catfish virus (CCV), frog virus 3 (FV3) (Chinchar
Evidence 23 Activity

Activity

MIC
Antiviral
2.51 µM

Target

S. iniae

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets. dbAMP 3.0 classified under the Anti-viral function class.
fish pathogens S. iniae (MIC 2.51 uM), L. garvieae (MIC 20.07 uM), V. anguillarum (MIC 2.51-5.02 uM), A-salmonicida (MIC >80.26
Evidence 24 Activity

Activity

MIC
Antiviral
20.07 µM

Target

L. garvieae

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

fish pathogens S. iniae (MIC 2.51 uM), L. garvieae (MIC 20.07 uM), V. anguillarum (MIC 2.51-5.02 uM), A-salmonicida (MIC >80.26 uM), human pathogens E. fae
Evidence 25 Activity

Activity

MIC
Antiviral
2.51-5.02 µM

Target

V. anguillarum

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

fish pathogens S. iniae (MIC 2.51 uM), L. garvieae (MIC 20.07 uM), V. anguillarum (MIC 2.51-5.02 uM), A-salmonicida (MIC >80.26 uM), human pathogens E. faecalis (MIC 1.26 uM), S. flexneri (M
Evidence 26 Activity

Activity

MIC
Antiviral
1.26 µM

Target

Enterococcus faecalis

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

07 uM), V. anguillarum (MIC 2.51-5.02 uM), A-salmonicida (MIC >80.26 uM), human pathogens E. faecalis (MIC 1.26 uM), S. flexneri (MIC 20.07 uM), and E. coli (MIC 80.26 uM). Viruses: It is active against ch
Evidence 27 Activity

Activity

MIC
Antiviral
20.07 µM

Target

S. flexneri

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

2.51-5.02 uM), A-salmonicida (MIC >80.26 uM), human pathogens E. faecalis (MIC 1.26 uM), S. flexneri (MIC 20.07 uM), and E. coli (MIC 80.26 uM). Viruses: It is active against channel catfish virus (CCV), f
Evidence 28 Activity

Activity

MIC
Antiviral
80.26 µM

Target

Escherichia coli

Source & Reference

dbAMP 3.0 DRAMP DRAVP 2.0

Other

IC >80.26 uM), human pathogens E. faecalis (MIC 1.26 uM), S. flexneri (MIC 20.07 uM), and E. coli (MIC 80.26 uM). Viruses: It is active against channel catfish virus (CCV), frog virus 3 (FV3) (Chinchar
Evidence 29 Activity

Activity

% Hemolysis
Hemolysis
5 %
[Ref.11713517]5% hemolytic activity at 100 µg/mL against human erythrocytes

Target

human erythrocytes

Source & Reference

Hemolytik APD_complete APD_hemolytic PD_Hemolysis
DRAMP4
Nature. 2001 Nov 15 414(6861):268-269.

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation. Hemolytik experimentally validated hemolytic peptide annotation.
Evidence 30 Activity

Activity

0% Hemolysis
Toxicity
6.25 µM
Hemolytic Cytotoxic
0% Hemolysis | 6.25 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Fungicidal effect of piscidin on Candida albicans: pore formation in lipid vesicles and activity in fungal membranes. | Biol Pharm Bull | 2008
Evidence 31 Activity

Activity

4% Hemolysis
Toxicity
12.5 µM
Hemolytic Cytotoxic
4% Hemolysis | 12.5 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Fungicidal effect of piscidin on Candida albicans: pore formation in lipid vesicles and activity in fungal membranes. | Biol Pharm Bull | 2008
Evidence 32 Activity

Activity

25% Hemolysis
Toxicity
25 µM
Hemolytic Cytotoxic
25% Hemolysis | 25 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Fungicidal effect of piscidin on Candida albicans: pore formation in lipid vesicles and activity in fungal membranes. | Biol Pharm Bull | 2008
Evidence 33 Activity

Activity

Toxicity
Hemolytic
Hemolytic_activity: [Ref.11713517]5% hemolytic activity at 100 µg/mL against human erythrocytes

Target

erythrocytes

Source & Reference

NA
DRAMP
Nature. 2001 Nov 15 414(6861):268-269.
Evidence 34 Hemolysis

Activity

5 %
% Hemolysis
[Ref.11713517]5% hemolytic activity at 100 µg/mL against human erythrocytes
Hemolysis

Target

human erythrocytes

Source & Reference

APD_complete APD_hemolytic HemoPI PD_Hemolysis
Nature. 2001 Nov 15 414(6861):268-269.
DRAMP4
APD_complete APD_hemolytic PD_Hemolysis

Other

Source Activity Label Source Definition
Hemolysis
APD_complete APD-derived hemolytic peptide annotation. APD_hemolytic APD hemolytic peptide annotation.